PRESCRIBING PATTERN OF ANTIDIABETIC DRUGS IN TYPE 2 DIABETES MELLITUS IN A RURAL TEACHING HOSPITAL IN SUB- HIMALYAN REGION

Kailash Nath Sharma, Aman Sharma, Aradhna Sharma, Tarun sharma

Abstract


Introduction: The number of people with Type 2 DM is increasing in every country with 80% of people with diabetes mellitus (DM) living in low
and middle income countries The treatment options for Type 2 DM has increased over the years with the availability of the various classes of
antidiabetic medications. The current objective of the study is to screen the prescription trends in Type 2 DM, assessing glycaemic control and
studying demographic and anthropometric parameters in a rural setting.
Material and Methods- This observational study was conducted prospectively in department of Medicine DRPGMCH Tanda at Kangra. One
hundred ninety patients of Type2 DM over a period of two months (July and august,2019) coming to medicine OPD were enrolled.
Results: Male to female ratio was 1.1:1. Minimum age of the patient was 30 yrs and maximum 88 yrs. BMI had no impact on glycemic control in
our study. Out of 190 patients, it was found that 56(29.5%) were on monotherapy and 136 (71.5%) patients were on combination therapy.
Biguanides were the most commonly prescribed drug as monotherapy (22.8%) and in combination (88.4%). Sulphonylureas (SU) was the second
preferred drug. In our study the third most common OHA was DPP4 I as monotherapy or in combination( 32.6%). 62.6% patients on antidiabetic
drugs had adequate glycaemic control while 37.4% patients had inadequate glycaemic control.
Conclusion: OHA still dominate the prescription pattern and biguanides are the most commonly prescribed drugs, but newer drugs like DPP4I
have found a significant place in prescription pattern.


Keywords


prescribing pattern, antidiabetic drugs, oral hypoglycaemic agents

Full Text:

PDF

References


Chan J C, Malik V, Jia W, et al. Diabetes in Asia : Epidemiology, Risk factors and pathophysiology. JAMA 2009;301:2129-40.

Ramachandran A, Wan Ma RC, Snehlatha C. Diabetes in Asia. Lancet 2010;375:408-418

IDF Diabetes Atlas, 4th Edition. International Diabetes Federation, 2009

Raheja BS, Kapur A, Bhoraskar A, Sathe SR, Jorgensen LN, Moorthi SR, etal. Diab Care Asia- India Study : Diabetes care in India – Current Status. J Assoc Physicians India 2001;49:717-22.

Nagpal J, Bhartia A. Quality of Diabertes Care in the Middle and High Income Group Populace: The Delhi Diabetes Community(DEDICOM) Survey. Diabetes Care2006; 29:2341-8.

The Effect Of Intensive Treatment of Diabetes on The Development and Progression of Long Term Complications in Insulin Dependent Diabetes Mellitus. The Diabetes Control and Complication Trial Research Group. NEJM J Med 1993;329:977-86.

Intensive Blood Glucose Control with Sulphonylureas or Insulin Compared with Conventional Treatment and Risk of Complications in Patients with Type 2 Diabetes (UKPDS33) UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:837-53.

Grant R, Adams AS, Trinacty CM, Zhang F, Kleinman K, Soumerai SB, etal. Relationship Between Patient Medication Adherence and Subsequent Clinical Inertia in Type 2 Diabetes Glycaemic Management. Diabetes Care 2007;30:807-12.

Mendes AB, Fittipaldi JA, Neves RC, Chacra AR, Moreira ED Jr. Prevelence and corelates of Inadequate Glycaemic Control: Results from a Nation Wide Suevey in 6,671 Adults with Diabetes in Brazil. Acta Diabetol 2010;47:137-45.

Mahmhood M, Raddy RC, Lahari JRS, Fatima S, Shinde P, Reddy SA, Pandit PS etal. Presciption Pattern Analysis of Anti diabetic Drugs in Diabetes Mellitus and Associated Comorbidities.Clin.Invest. (Lond.)(2018) 7(1)

Rani J, Reddy S. Prescribing Pattern of Antidiabetic Drugs in Urban Population of Hyderabad. Natl J Physiol Pharm Pharmacol 2015;5:5-9.

Le Nguyen TD, Tran TM, Kusama K, et al. Vietnamese type 2 diabetic subjects with normal BMI but high body fat. Diabetes Care. 2003;26(6):1946–1947.

Aggarwal AA, Jadhav PR, Deshmukh YA. Prescribing Pattern nad Eficay of Anti diabetic Drugs in Maintaining Optimal Glycaemic Levels in Diabetic Patients.J Basic Clin Pharma 2014;5: 79-83.

Adibe MO, Aguwa CN, Ukwe CV, Okonta JM, Udeogaranya PO. Outpatient utilization of anti-diabetic drugs in the South Eastern Nigeria. Int J Drug Dev Res 2009;1:27-36.

Rajeshwari S, Adikhari P, Pai MR. Drug utilisation study in geriatric type 2 diabetic patients. J Clin Diagn Res 2007;1:440-3.

Truter I. An investigation into antidiabetic medication prescribing in South Africa. J Clin Pharm Ther 1998;23:417-22.

Sultana G, Kapur P, Aqil M, Alam MS, Pillai KK. Drug utilization of oral hypoglycemic agents in a university teaching hospital in India. J Clin Pharm Ther 2010;35:267-77.

Sutharson L, Hariharan RS, Vamsadhara C. Drug utilization study in diabetology outpatient setting of a tertiary hospital. Indian J Pharmacol 2003;35:237-40.

Patel B, Oza B, Patel KP, Malhotra SD, Patel VJ. Pattern of antidiabetic drugs use in type-2 diabetic patients in a medicine outpatient clinic of a tertiary care teaching hospital. Int J Basic Clin Pharmacol 2013;2:485-91.

Willey CJ, Andrade SE, Cohen J, Fuller JC, Gurwitz JH. Polypharmacy with oral antidiabetic agents: An indicator of poor glycemic control. Am J Manag Care 2006;12:435-40.

Ben Abdelaziz A, Soltane I, Gaha K, Thabet H, Tlili H, Ghannem H. Predictive factors of glycemic control in patients with type 2 diabetes mellitus in primary health care. Rev Epidemiol Sante Publique 2006;54:443-52.

Moreira ED Jr, Neves RC, Nunes ZO, de Almeida MC, Mendes AB, Fittipaldi JA, et al. Glycemic control and its correlates in patients with diabetes in Venezuela: Results from a nationwide survey. Diabetes Res Clin Pract 2010;87:407-14


Refbacks

  • There are currently no refbacks.